MenACWY-CRM197

BIOLOGICAL2 trials

Sponsors

Novartis Vaccines, Novartis

Conditions

MeningitisMeningococcal DiseaseMeningococcal Infection

Phase 2

Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months

CompletedNCT00601731

Novartis VaccinesMeningococcal Disease

Start: 2008-02-29End: 2010-09-30Updated: 2014-10-24

Phase 3

Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

CompletedNCT00806195

NovartisMeningitis, Meningococcal Infection

Start: 2008-12-31End: 2011-11-30Updated: 2013-07-09